<DOC>
	<DOC>NCT00294255</DOC>
	<brief_summary>The study aims to assess the efficacy and tolerability of risperidone added to lithium, valproate or lamotrigine in patients experiencing a manic episode with depressive or irritable features.</brief_summary>
	<brief_title>Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania</brief_title>
	<detailed_description>- The study aims to assess the efficacy and tolerability of risperidone added to lithium, valproate or lamotrigine, or any combination of the three, in patients experiencing a manic episode with depressive or irritable symptoms. - To assess the back ground and baseline features associated with response/non-response to risperidone plus mood stabilizer in patients with mania with depressive or irritable features. - To assess the symptomatic dimensions of response of risperidone added to mood stabilizers in patients with mania with depressive or irritable features.</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>DSM IV diagnosis of bipolar disorder, currently manic, or mixed manic YMRS score&gt;/= 16 One or more of following: 1. 3 MADRS depression items scoring &gt;/=3 2. 3 BISS depression items scoring &gt;/=3 3. YMRS irritability and aggressive items sum score&gt;/=4 Taking lithium, valproate or lamotrigine at stable dose for 4 wks or longer, with adequate serum level age 18 and over Male or female Inpatient or outpatient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>mixed mania</keyword>
	<keyword>depression</keyword>
	<keyword>irritability</keyword>
</DOC>